NINA SZULEWSKI: Open Payments
NPI 1326349879 · DARTMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,037 in 37 payments from 13 companies in 2025. Trend: 2023 $68 · 2024 $627 · 2025 $1,037
Food & beverage: $1,037
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $406 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| UCB, Inc. | 3 | $88 |
| Lundbeck LLC | 4 | $83 |
| Eisai Inc. | 2 | $73 |
| Lilly USA, LLC | 3 | $65 |
| Genentech USA, Inc. | 2 | $42 |
| EMD Serono, Inc. | 1 | $36 |
| Neurelis, Inc. | 1 | $30 |
| Sage Therapeutics, LLC | 1 | $24 |
Products named: QULIPTA, UBRELVY, COBENFY, REXULTI, Leqembi, Rystiggo, KISUNLA, Ocrevus Zunovo.
Industry payments across MA — which companies pay providers there.
